Advanced Heart Failure-Transplant-MCS

​​​​​​​​​​​​​​​​​​​RHC Rapid Access for Referring Providers: 1.866.UWHEART (894.3278)

UW Medicine Regional Heart Center’s Advanced Heart Failure program provides comprehensive care that is unique among medical centers. Our program offers the complete range of treatment options tailored to each patient’s needs and appropriate to their stage of heart disease. The Regional Heart Center (RHC) serves the Washington, Wyoming, Alaska, Montana, and Idaho (WWAMI) region.

Our clinical team is led by nationally recognized cardiologists who specialize in advanced heart failure, and cardiac surgeons with advanced training in device therapies and heart transplant. Also included on the team are cardiac anesthesiologists, infectious disease, palliative care, cardiac imaging specialists, cardiothoracic nurse practitioners, physician assistants, and nurses with advanced training and experience in the evaluation and treatment of patients with advanced heart failure.

Collaborative Approach:

Our multidisciplinary team meets twice weekly to discuss all patients requiring transplant or mechanical circulatory support (MCS), allowing for broad-based discussion among surgeons, cardiologists, ARNPs and PAs, and other practitioners. The patient and referring physician receive a synthesis of this discussion, with decisions and recommendations.

Our program offers:

  • Expert heart failure management
  • Heart transplantation
  • Multiple organ transplant, including heart-kidney, heart-lung, heart-liver
  • Mechanical circulatory support (MCS) implant and management, including:
    • Total artificial heart (TAH) and Freedom Driver
    • Ventricular Assist Devices (VAD), both HeartMate II and HeartWare
    • Access to investigational devices in clinical trials
  • Bridge-to-Transplant (BTT) implant of MCS devices
  • Destination Therapy (DT) implant of MCS devices—our program has been continuously certified since 2009 by The Joint Commission
  • Advanced temporary emergent support, including:
    • Extracorporeal Life Support (ECLS)
    • Impella
    • CentriMag
    • Tandem Heart
  • Multidisciplinary care, including social worker, nutrition, transplant and anticoagulation pharmacy, infectious disease, pulmonology, gastroenterology, nephrology, hepatology, financial counseling, palliative care, and more
  • Enrollment in prospective, randomized clinical trials
  • 24-hour, on-site cardiothoracic intensive care unit service
  • 24-hour MCS nurse coordinator on call for patients, staff, and physicians
  • Patient and family centered care—the Transplant Patient and Family Advisory Council lends first-hand experience and insight to help create the best experience of transplant care

Our patient outcomes speak to our success as a quaternary care center:

  • Our heart transplant outcomes are superb: Half of patients who receive a heart at Regional Heart Center are still alive after  17 years; the national average is closer to 11 years
  • We have implanted 541 Ventricular Assist Devices (VADs) since 1997 and 22 Total Artificial Hearts since 2012 
  • 97 patients are currently actively supported on mechanical circulatory devices
  • 734 patients have received heart transplants

We contribute to the advancement of disease management:

  • We participate in groundbreaking research and clinical trials that help establish experimental treatments as new standards of care. 
  • Current trials include:
– EXPAND OCS (Heart-in-a-Box) Donor heart retrieval
– ENDURANCE-HeartWare Destination Therapy LVAD; Top 10 overall in U.S. trial enrollment
– LATERAL-Minimally invasive HeartWare LVAD implantation -3rd in U.S. trial enrollment
– MOMENTUM-HeartMate 3 LVAD
– Impella RP
– PARACHUTE-Ventricular partitioning device
– PARAGON-HF
         -Tricuspid valve study
        -Stem cell trials
        -Computational fluid dynamics

Training and Education:

– National CME conference provider
– National and international educational initiatives
– Fellowship programs in Cardiology and CT Surgery
          -Regional and surgical training site for Heartware 
         -Training site for Abiomed

Recognition of our Advanced Heart Failure program includes:

  • Joint Commission certified Destination Therapy VAD Program since 2009
  • In 2014, Award of Excellence in Healthcare Quality by Qualis Health for demonstrated leadership and innovation in improving healthcare practices
  • Designation as a Vanguard Center in 2012; received 3 additional annual Vanguard Awards by the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) for exemplary data and regulatory compliance

Referring your patient to the Advanced Heart Failure-Transplant-MCS program

Any one of the below conditions may identify a patient with serious heart failure that warrants consideration for advanced therapies:

  • Two or more heart failure hospitalizations
  • High diuretic dose: > 100 mg of furosemide daily
  • Worsening renal function: BUN > 40 mg/dL; creatinine > 1.8 mg/dL 
  • Systolic BP < 90 mmHg
  • Need for inotropic support
  • Inability to initiate ACE inhibitors or beta blockers
  • Need to stop or decrease ACE inhibitors or beta blockers
  • LVEF < 25% – especially in younger patients  
  • Seattle Heart Failure Model (SHFM) Mortality >15%
    SHFM: http://depts.washington.edu/shfm/

Contact Information

Where is the advanced heart failure clinic located and who are the providers?

The clinic is located at the Regional Heart Center on the main floor of University of Washington Medical Center. The address is 1959 N.E. Pacific St., Seattle, WA 98195.

Advanced Heart Failure Cardiology

Cardiac Surgery

RHC Rapid Access for Referring Providers: 1.866.UWHEART (894.3278)

 

Advanced Heart Failure - VADs - Heart Transplant Referrals

​Phone: 206.598.8069, Fax: 206.598.7451

If you have any other questions or need further information, you may also contact the Regional Heart Center Physician Liaison at uwheart@uw.edu or 206.598.3473.​ ​​​​​​

​​